Company
Anaconda Biomed
- Biotech
- Location:
- Sant Quirze del Valles, Spain
Description
Anaconda Biomed develops next-generation neurovascular endovascular devices, including the ANA5 funnel catheter, which provides high-efficiency aspiration, controlled temporary flow arrest, and a larger receptacle for clot collection during mechanical thrombectomy for large-vessel occlusion stroke.
Anaconda Biomed is located in the Barcelona ecosystem.
Related
MethinksMethinks detects large-vessel occlusions and hemorrhages on non-contrast CT using AI-enhanced analysis, delivers alerts and presents…
AortyxAortyx develops a bioresorbable biomimetic endovascular patch and a dual-steerable catheter delivery system to seal aortic dissection entry…
LaNua MedicalLaNua Medical is developing ECORE™, an embolization device designed to block blood flow, address unwanted embolization reflux, and give…
VersonoVersono develops the ProSonic™ System, an intravascular ultrasonic platform that uses axial and radial ultrasonic energy to cross complex…
Nimble DiagnosticsNimble Diagnostics develops a non-invasive, portable monitoring device that detects stent complications, measuring stent malfunction with…
LUMA VISIONLUMA VISION develops imaging hardware, software and machine-learning systems for interventional cardiac imaging including an…
Ability PharmaAbility Pharma develops oral targeted anticancer compounds that induce cytotoxic autophagy in cancer cells and advances clinical-stage…
AplagonAplagon develops a therapeutic called APAC, a vascular-injury targeting molecule that combines antiplatelet, anticoagulant, and…
BiorceBiorce develops Aika, an AI-driven clinical trial operating system that generates trial documents, supports protocol design, feasibility,…